K M C Speciality Hospitals (India) (KMCSHIL)₹164.49−0.48%Hospital
In the Jun 2026 quarter (standalone), K M C Speciality Hospitals (India) reported sales of ₹92.16 Cr, up 37.3% from Jun 2025, and net profit of ₹16.97 Cr, up 112.4% year on year. For the year to Mar 2026, sales were ₹306 Cr and net profit ₹46.93 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42.02 | 49.01 | 45.03 | 53.08 | 56.06 | 61.11 | 61.03 | 67.11 | 75.07 | 82.13 | 82.03 | 92.16 |
| Expenses | 31.06 | 35.05 | 33.06 | 40.04 | 44.08 | 45.04 | 46.11 | 50.10 | 54.11 | 57.06 | 56.06 | 63.12 |
| Operating Profit | 10.99 | 13.98 | 11.99 | 12.97 | 12.98 | 15.97 | 14.98 | 15.99 | 20.97 | 24.98 | 25.98 | 27.97 |
| OPM % | 25.9% | 28.9% | 25.9% | 23.9% | 21.9% | 25.9% | 24.9% | 24.9% | 27.9% | 29.9% | 30.9% | 30.9% |
| Other Income | 1.01 | 1.01 | 1.01 | 1.01 | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 2.01 |
| Interest | 0.00 | 0.00 | 0.00 | 2.01 | 3.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 |
| Depreciation | 2.01 | 2.01 | 3.01 | 4.01 | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 | 5.01 | 6.01 | 6.01 |
| Profit before tax | 9.02 | 12.03 | 9.03 | 7.01 | 5.01 | 10.02 | 9.01 | 10.03 | 15.04 | 18.06 | 20.04 | 22.06 |
| Tax % | 26.0% | 24.0% | 25.0% | 26.0% | 27.0% | 25.0% | 49.0% | 25.0% | 26.0% | 26.0% | 26.0% | 26.0% |
| Net Profit | 6.98 | 8.99 | 6.98 | 5.99 | 3.99 | 7.98 | 4.99 | 7.99 | 10.97 | 13.97 | 14.98 | 16.97 |
| EPS (Rs) | 0.41 | 0.57 | 0.42 | 0.33 | 0.23 | 0.45 | 0.27 | 0.45 | 0.65 | 0.83 | 0.89 | 1.01 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 43.07 | 55.09 | 71.08 | 82.08 | 96.09 | 103 | 136 | 156 | 177 | 232 | 306 | 331 |
| Expenses | 35.05 | 42.06 | 56.10 | 66.14 | 75.14 | 79.09 | 99.10 | 114 | 129 | 174 | 217 | 230 |
| Operating Profit | 7.98 | 11.99 | 13.98 | 15.98 | 20.99 | 22.99 | 36.95 | 41.97 | 47.94 | 56.93 | 87.95 | 99.90 |
| OPM % | 18.9% | 22.9% | 20.0% | 19.9% | 21.9% | 22.9% | 27.9% | 26.9% | 26.9% | 24.9% | 28.9% | 30.2% |
| Other Income | 1.01 | 0.00 | 0.00 | 2.01 | 1.01 | 2.01 | 2.01 | 3.01 | 4.01 | 3.01 | 5.01 | 6.04 |
| Interest | 2.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 10.03 | 9.03 | 8.04 |
| Depreciation | 3.01 | 3.01 | 4.01 | 4.01 | 5.01 | 6.01 | 7.01 | 8.02 | 9.01 | 19.02 | 22.02 | 22.04 |
| Profit before tax | 4.01 | 8.02 | 10.02 | 12.03 | 17.03 | 18.03 | 32.07 | 36.09 | 41.12 | 32.05 | 63.14 | 75.20 |
| Tax % | 21.0% | 33.0% | 32.0% | 30.0% | 30.0% | 29.0% | 26.0% | 26.0% | 25.0% | 32.0% | 26.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 2.99 | 4.99 | 6.99 | 8.98 | 11.96 | 12.97 | 23.93 | 26.93 | 29.92 | 20.96 | 46.93 | 56.89 |
| EPS (Rs) | 0.19 | 0.32 | 0.40 | 0.52 | 0.71 | 0.77 | 1.45 | 1.63 | 1.85 | 1.30 | 2.86 | 3.38 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16.01 | 15.99 | 15.99 | 15.98 | 16.00 | 15.98 | 15.96 | 15.99 | 15.98 | 15.99 | 15.98 | 16.01 |
| Reserves | −6.01 | −3.01 | 7.98 | 13.97 | 22.98 | 33.92 | 46.89 | 69.89 | 96.77 | 127 | 148 | 194 |
| Borrowings | 14.00 | 9.99 | 5.99 | 14.97 | 10.00 | 8.99 | 28.96 | 28.98 | 49.93 | 81.97 | 88.89 | 84.03 |
| Other Liabilities | 6.96 | 5.97 | 7.96 | 7.96 | 9.95 | 10.94 | 12.94 | 12.94 | 17.90 | 37.83 | 31.84 | 37.81 |
| Total Liabilities | 30.96 | 28.94 | 37.92 | 52.88 | 59.93 | 69.83 | 105 | 129 | 182 | 264 | 285 | 332 |
| Fixed Assets | 24.97 | 22.95 | 23.94 | 36.92 | 35.96 | 38.90 | 73.84 | 74.90 | 83.84 | 206 | 248 | 248 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 5.98 | 33.90 | 0.99 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 5.99 | 6.99 | 13.98 | 15.96 | 23.97 | 30.93 | 28.92 | 47.92 | 62.84 | 56.88 | 37.90 | 83.81 |
| Inventories | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 3.99 | 3.99 |
| Trade receivables | 1.01 | 1.99 | 1.99 | 1.99 | 2.01 | 1.99 | 2.99 | 3.99 | 3.99 | 3.99 | 6.01 | 6.99 |
| Cash & equivalents | 0.00 | 0.00 | 0.99 | 3.98 | 5.98 | 9.96 | 17.93 | 32.87 | 38.86 | 22.90 | 8.96 | 54.78 |
| Total Assets | 30.96 | 28.94 | 37.92 | 52.88 | 59.93 | 69.83 | 105 | 129 | 182 | 264 | 285 | 332 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 5.01 | 6.02 | 10.03 | 12.03 | 16.05 | 11.03 | 26.06 | 29.07 | 32.12 | 38.09 | 58.18 | 79.28 |
| Cash from investing activity | −1.01 | −1.01 | −4.01 | −19.04 | −9.01 | −8.01 | −43.06 | −29.05 | −48.04 | −56.05 | −51.06 | −17.02 |
| Cash from financing activity | −5.02 | −5.01 | −5.02 | 6.02 | −5.02 | −4.01 | 18.04 | −1.01 | 16.05 | 20.06 | −2.01 | −21.07 |
| Net cash flow | 0.00 | 0.00 | 1.01 | −1.01 | 1.01 | −1.01 | 1.01 | 0.00 | 0.00 | 3.01 | 4.01 | 41.09 |
| Capex | 0.97 | 0.81 | 4.30 | 15.76 | 3.21 | 3.45 | 40.82 | 13.49 | 44.10 | 75.26 | 63.82 | 16.62 |
| Free cash flow | 4.99 | 4.99 | 5.99 | −2.99 | 12.98 | 6.99 | −14.98 | 15.98 | −11.98 | −36.96 | −5.99 | 62.92 |
| CFO / OP % | 112.0% | 91.0% | 94.0% | 100.0% | 113.0% | 66.0% | 120.0% | 102.0% | 100.0% | 101.0% | 112.0% | 99.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 11 | 12 | 11 | 12 | 7 | 7 | 8 | 9 | 9 | 8 | 8 | 8 |
| Inventory days | 42 | 32 | 28 | 24 | 29 | 59 | 39 | 33 | 36 | 31 | 38 | 31 |
| Days payable | 169 | 158 | 134 | 143 | 161 | 115 | 117 | 96 | 102 | 113 | 153 | 82 |
| Cash conversion cycle | −114 | −111 | −93 | −106 | −124 | −47 | −67 | −52 | −55 | −72 | −104 | −41 |
| Working capital days | −70 | −60 | −46 | −37 | −28 | −18 | −15 | −27 | −22 | −73 | −22 | −19 |
| ROCE % | 8.0% | 23.9% | 35.0% | 29.0% | 28.9% | 33.0% | 24.9% | 31.9% | 26.9% | 21.9% | 16.9% | 26.0% |
For the Jun 2026 quarter, K M C Speciality Hospitals (India) reported sales of ₹92.16 Cr, up 37.3% year on year and net profit of ₹16.97 Cr, up 112.4% year on year. The operating margin was 30.9%.
K M C Speciality Hospitals (India)'s sales for the year to Mar 2026 were ₹306 Cr; over the last twelve months they were ₹331 Cr.
Net profit for the year to Mar 2026 was ₹46.93 Cr, and ₹56.89 Cr over the last twelve months. Earnings per share over the same trailing period were ₹3.38.
K M C Speciality Hospitals (India) reported borrowings of ₹84.03 Cr at Mar 2026, against cash and equivalents of ₹54.78 Cr.
Cash from operations was ₹79.28 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹62.92 Cr.